Physician profile
Rawish Fatima
NPI 1023585924
$401.17
in general payments reported to CMS, 2019-2025
9 companies · $45.24 in 2025
The $45.24 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $83.03 · 2023: $162 · 2024: $111 · 2025: $45.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $123.04 | 2023 | Evenity, Prolia |
| Abbvie INC. | $83.03 | 2022 | |
| Alexion Pharmaceuticals, INC. | $61.89 | 2024 | Strensiq |
| Astrazeneca Pharmaceuticals LP | $30.84 | 2025 | Saphnelo |
| Actelion Pharmaceuticals US, INC. | $27.54 | 2024 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $21.85 | 2024 | Benlysta |
| Octapharma USA, INC. | $19.58 | 2023 | Octagam Immune Globulin (Human) |
| Aurinia Pharma U.S., INC. | $19.00 | 2023 | |
| Pfizer INC. | $14.40 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rawish Fatima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.